EXL — Elixinol Wellness Income Statement
0.000.00%
Last trade - 00:00
- AU$6.96m
- AU$7.57m
- AU$8.48m
- 24
- 58
- 31
- 34
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 31.3 | 15.1 | 9.38 | 7.08 | 8.48 |
Cost of Revenue | |||||
Gross Profit | 16.9 | 6.77 | 4.94 | 3.26 | 3.63 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 118 | 114 | 26.8 | 18.1 | 16.4 |
Operating Profit | -86.3 | -99 | -17.4 | -11 | -7.92 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -88 | -100 | -17.1 | -10.6 | -7.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -80.5 | -104 | -17 | -10.6 | -7.51 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -82.9 | -105 | -17 | -10.6 | -7.51 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -82.9 | -105 | -17 | -10.6 | -7.51 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.168 | -0.177 | -0.037 | -0.024 | -0.01 |